ApprovalTrail

Approval · Notice of Compliance 1391 · 2003

CORVERT INJECTION: Notice of Compliance 1391

Issued September 16, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
1391
Date
September 16, 2003
Company
Pfizer Canada UlcKirkland, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Antiarrhythmic agent

Products in this notice

BrandDINStatus today
CORVERT INJECTION02242470Marketed

Medicinal ingredients